Point-of-care lateral flow assays for tuberculosis and cryptococcal antigenuria predict death in HIV infected adults in Uganda
about
Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adultsDetection of lipoarabinomannan (LAM) in urine is indicative of disseminated TB with renal involvement in patients living with HIV and advanced immunodeficiency: evidence and implications.Detection of lipoarabinomannan (LAM) in urine is an independent predictor of mortality risk in patients receiving treatment for HIV-associated tuberculosis in sub-Saharan Africa: a systematic review and meta-analysisPredictors and outcomes of mycobacteremia among HIV-infected smear- negative presumptive tuberculosis patients in Uganda.Implementation and operational research: Integrated pre-antiretroviral therapy screening and treatment for tuberculosis and cryptococcal antigenemiaHigh Genotypic Discordance of Concurrent Mycobacterium tuberculosis Isolates from Sputum and Blood of HIV-Infected Individuals.Comparative performance characteristics of the urine lipoarabinomannan strip test and sputum smear microscopy in hospitalized HIV-infected patients with suspected tuberculosis in Harare, Zimbabwe.Evaluation of five conventional and molecular approaches for diagnosis of cryptococcal meningitis in non-HIV-infected patients.Diagnostic Accuracy of Lateral Flow Urine LAM Assay for TB Screening of Adults with Advanced Immunosuppression Attending Routine HIV Care in South AfricaRapid urine-based screening for tuberculosis to reduce AIDS-related mortality in hospitalized patients in Africa (the STAMP trial): study protocol for a randomised controlled trialIncremental Yield of Including Determine-TB LAM Assay in Diagnostic Algorithms for Hospitalized and Ambulatory HIV-Positive Patients in Kenya.Diagnostic accuracy, incremental yield and prognostic value of Determine TB-LAM for routine diagnostic testing for tuberculosis in HIV-infected patients requiring acute hospital admission in South Africa: a prospective cohortCryptococcal Antigen Screening in Patients Initiating ART in South Africa: A Prospective Cohort StudyInverting the pyramid: increasing awareness of mycobacterial sepsis in sub-Saharan Africa.Cryptococcal disease and the burden of other fungal diseases in Uganda; Where are the knowledge gaps and how can we fill them?The current treatment landscape: other fungal diseases (cryptococcosis, fusariosis and mucormycosis).Point-of-Care Testing for Cryptococcal Disease Among Hospitalized Human Immunodeficiency Virus-Infected Adults in Ethiopia.Clinic-Based Urinary Lipoarabinomannan as a Biomarker of Clinical Disease Severity and Mortality Among Antiretroviral Therapy-Naive Human Immunodeficiency Virus-Infected Adults in South Africa.Discovery of a unique Mycobacterium tuberculosis protein through proteomic analysis of urine from patients with active tuberculosis.The epidemiology of febrile illness in sub-Saharan Africa: implications for diagnosis and management.CD4 Cell Count Threshold for Cryptococcal Antigen Screening of HIV-Infected Individuals: A Systematic Review and Meta-analysis.Opportunistic diseases diminish the clinical benefit of immediate antiretroviral therapy in HIV-tuberculosis co-infected adults with low CD4+ cell counts
P2860
Q24185754-37957293-CF11-4C29-999E-5214F2601639Q26765388-8CD621D1-F76B-48DE-879D-0FF48C6CB0F5Q28073433-68915B8D-8FDC-409F-9D3D-FC8B013E5E75Q35094781-C2F8AAC2-B6DF-45D4-8085-889120C485DEQ35170385-A12AE623-B34F-4D67-A283-334DADD9F404Q35691978-26B46377-E42F-4E31-A0DD-11D7A3AB237FQ35900718-48B52308-C8F7-4B32-A771-2F1CFD303FEBQ35984568-D04A5842-57B1-4B48-9F15-FE4C5104EB20Q36043516-9AE2C782-32FA-4C98-A28E-2EC089617D35Q36141910-D364ABFB-CA95-44DD-8B84-75E799FD8E73Q36261370-482BA2E0-6D64-4CD5-AA73-8A375EA23D9FQ36315432-E8E6DA5A-B8A4-41DF-B7CE-E10A287846B4Q36543833-28550E78-0A31-4F06-BBD6-E544ECC9AB2FQ36894285-77E0FE2A-FE28-418A-B52C-A834430EEAC8Q38602639-289C3F4F-3AB6-43BA-BCCB-673B7CEAAA7CQ39189670-1402A0C1-D0EC-41D8-B05E-57B0D76815BFQ40092528-95313C86-10EE-4BE6-8E5E-8A8D96B130DDQ41923907-8B8EF0CD-BE8B-44C9-9D5C-808E5DCF8459Q47202823-C780FC5E-EA82-47C1-92DE-CDF4E53886F0Q49896091-876E0645-EFBA-4CBC-BDA0-812F13AB807AQ51365549-B24CFDB7-8A68-4788-A945-4279C9F18938Q56909177-6062F06B-CB16-4221-AC6D-8683CF309B6D
P2860
Point-of-care lateral flow assays for tuberculosis and cryptococcal antigenuria predict death in HIV infected adults in Uganda
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Point-of-care lateral flow ass ...... HIV infected adults in Uganda
@ast
Point-of-care lateral flow ass ...... HIV infected adults in Uganda
@en
type
label
Point-of-care lateral flow ass ...... HIV infected adults in Uganda
@ast
Point-of-care lateral flow ass ...... HIV infected adults in Uganda
@en
prefLabel
Point-of-care lateral flow ass ...... HIV infected adults in Uganda
@ast
Point-of-care lateral flow ass ...... HIV infected adults in Uganda
@en
P2093
P2860
P50
P1433
P1476
Point-of-care lateral flow ass ...... HIV infected adults in Uganda
@en
P2093
Gloria Lubega
Jerrold Ellner
Lydia Nakiyingi
Maunank Shah
Olive Mbabazi
Susan E Dorman
Yukari C Manabe
P2860
P304
P356
10.1371/JOURNAL.PONE.0101459
P407
P577
2014-07-07T00:00:00Z